Kronos Bio Stock Price on October 4, 2024
| KRON Stock | USD 0.89 0.01 1.11% |
If you're considering investing in Kronos Stock, it is important to understand the factors that can impact its price. As of today, the current price of Kronos Bio stands at 0.89, as last reported on the 26th of November, with the highest price reaching 0.92 and the lowest price hitting 0.88 during the day. Kronos Bio has Sharpe Ratio of -0.0377, which conveys that the firm had a -0.0377% return per unit of risk over the last 3 months. Kronos Bio exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kronos Bio's Standard Deviation of 3.32, risk adjusted performance of (0.01), and Mean Deviation of 2.5 to check out the risk estimate we provide.
At this time, Kronos Bio's Total Stockholder Equity is very stable compared to the past year. As of the 26th of November 2024, Liabilities And Stockholders Equity is likely to grow to about 279.9 M, while Common Stock Total Equity is likely to drop about 39.2 K. . At this time, Kronos Bio's Price Book Value Ratio is very stable compared to the past year. As of the 26th of November 2024, Price Earnings To Growth Ratio is likely to grow to 0.04, while Price To Sales Ratio is likely to drop 9.18. Kronos Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Kronos |
Sharpe Ratio = -0.0377
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | KRON |
Estimated Market Risk
| 3.39 actual daily | 30 70% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Kronos Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kronos Bio by adding Kronos Bio to a well-diversified portfolio.
Price Book 0.4903 | Enterprise Value Ebitda 0.8087 | Price Sales 6.3698 | Shares Float 42.9 M | Wall Street Target Price 1.625 |
Related Headline
Seres Therapeutics Headline on 4th of October 2024
Filed transaction by Seres Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3
Kronos Bio Valuation on October 4, 2024
It is possible to determine the worth of Kronos Bio on a given historical date. On October 4, 2024 Kronos was worth 0.96 at the beginning of the trading date compared to the closed value of 0.99. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Kronos Bio stock. Still, in general, we apply an absolute valuation method to find Kronos Bio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kronos Bio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Kronos Bio's related companies.
| Open | High | Low | Close | Volume | |
| 0.95 | 0.99 | 0.95 | 0.96 | 22,875 | |
10/04/2024 | 0.96 | 1.00 | 0.96 | 0.99 | 26,533 |
| 1.00 | 1.00 | 0.96 | 0.99 | 33,316 |
| Backtest Kronos Bio | | | Kronos Bio History | | | Kronos Bio Valuation | Previous | Next |
Kronos Bio Trading Date Momentum on October 4, 2024
| On October 07 2024 Kronos Bio was traded for 0.99 at the closing time. The top price for the day was 1.00 and the lowest listed price was 0.96 . The trading volume for the day was 33.3 K. The trading history from October 7, 2024 did not cause price change. The trading delta at closing time against the current closing price is 3.03% . |
Kronos Bio Fundamentals Correlations and Trends
By evaluating Kronos Bio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Kronos Bio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Kronos financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Kronos Bio Stock history
Kronos Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kronos is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kronos Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kronos Bio stock prices may prove useful in developing a viable investing in Kronos Bio
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 57.7 M | 55.8 M | |
| Net Loss | -119.9 M | -125.9 M |
Kronos Bio Quarterly Net Working Capital |
|
Kronos Bio Stock Technical Analysis
Kronos Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Kronos Bio Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Kronos Bio cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Kronos Bio November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Kronos Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kronos Bio shares will generate the highest return on investment. By undertsting and applying Kronos Bio stock market strength indicators, traders can identify Kronos Bio entry and exit signals to maximize returns
Kronos Bio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Kronos Bio's price direction in advance. Along with the technical and fundamental analysis of Kronos Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kronos to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.62) | |||
| Treynor Ratio | (0.27) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kronos Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Kronos Stock, please use our How to Invest in Kronos Bio guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kronos Bio. If investors know Kronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kronos Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.43) | Revenue Per Share 0.143 | Quarterly Revenue Growth 0.442 | Return On Assets (0.28) | Return On Equity (0.63) |
The market value of Kronos Bio is measured differently than its book value, which is the value of Kronos that is recorded on the company's balance sheet. Investors also form their own opinion of Kronos Bio's value that differs from its market value or its book value, called intrinsic value, which is Kronos Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kronos Bio's market value can be influenced by many factors that don't directly affect Kronos Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kronos Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kronos Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kronos Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.